MJFG
PFE icon

Mars Jewett Financial Group’s Pfizer PFE Stock Holding History

Mars Jewett Financial Group’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$451K Buy
18,737
+94
+0.5% +$2.46K 0.09% 33
2026
Q1 		$523K Buy
18,643
+17
+0.1% +$453 0.17% 26
2025
Q4 		$517K Buy
+18,626
New +$470K 0.15% 27

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Mars Jewett Financial Group's PFE Position: Q2 2026 in Review

Mars Jewett Financial Group increased its Pfizer (PFE) stake by 0.5% in Q2 2026, buying an estimated $2.46K and bringing the position to 18,737 shares worth $451K. The position accounts for 0.09% of the portfolio, ranked #33.

Mars Jewett Financial Group first reported a position in PFE in Q4 2025 and has held it in 3 quarters since. The position peaked at $523K in Q1 2026. 2,820 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Mars Jewett Financial Group held 18,737 shares of Pfizer worth $451K as of Q2 2026.
  • Mars Jewett Financial Group bought 94 Pfizer shares in Q2 2026, an estimated $2.46K.
  • Pfizer made up 0.09% of Mars Jewett Financial Group's portfolio in Q2 2026, its #33 holding.
  • Mars Jewett Financial Group first reported a position in Pfizer in Q4 2025 and has held it in 3 quarters since.
  • Mars Jewett Financial Group's Pfizer position peaked at $523K in Q1 2026.
  • 2,820 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Mars Jewett Financial Group's 13F filing for Q2 2026, filed 14 Aug 2026.